Nemaura Medical Provides Update on Nasdaq Compliance Status and Process
NMRDDelisted Stock | USD 0.93 0.01 1.06% |
About 61% of Nemaura Medical's investor base is looking to short. The analysis of overall sentiment of trading Nemaura Medical pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Nemaura Medical's historical and current headlines, can help investors time the market. In addition, many technical investors use Nemaura Medical stock news signals to limit their universe of possible portfolio assets.
Nemaura Medical pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Nemaura daily returns and investor perception about the current price of Nemaura Medical as well as its diversification or hedging effects on your existing portfolios.
Nemaura |
LOUGHBOROUGH, Sept. 14, 2023 -- Nemaura Medical, Inc. , a medical technology company focused on developing and commercialising non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today provided an update regarding the status of its compliance with Nasdaq continued listed standards and anticipated next steps to maintain its listing on The Nasdaq Capital Market. As previously disclosed by the C
Read at finance.yahoo.com
Nemaura Medical Fundamental Analysis
We analyze Nemaura Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nemaura Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nemaura Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Shares Shorted
Number Of Shares Shorted Comparative Analysis
Nemaura Medical is currently under evaluation in number of shares shorted category among its peers. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
Nemaura Medical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Nemaura Medical pink sheet to make a market-neutral strategy. Peer analysis of Nemaura Medical could also be used in its relative valuation, which is a method of valuing Nemaura Medical by comparing valuation metrics with similar companies.
Peers
Nemaura Medical Related Equities
MOVE | Movano | 6.20 | ||||
NPCE | Neuropace | 3.50 | ||||
CVRX | CVRx | 3.33 | ||||
AORT | Artivion | 1.82 | ||||
OFIX | Orthofix Medical | 1.40 | ||||
ELMD | Electromed | 0.91 | ||||
SRDX | SurModics | 0.40 | ||||
BJDX | Bluejay Diagnostics | 1.54 | ||||
NVNO | EnVVeno Medical | 1.58 | ||||
MODD | Modular Medical | 2.80 | ||||
SSKN | STRATA Skin | 5.25 | ||||
NXL | Nexalin Technology | 14.05 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in Nemaura Pink Sheet
If you are still planning to invest in Nemaura Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nemaura Medical's history and understand the potential risks before investing.
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |